Key result
Large-scale GWAS reveal novel pathophysiological processes and potential therapeutic approaches for stroke.
Why the study?
Stroke is a complex, heterogeneous leading cause of death worldwide, and more research is needed to interpret findings from large-scale genome-wide association studies deciphering its genetic basis.
This review highlights the progress in stroke genetics and its potential to reveal novel pathophysiological processes, accelerate therapeutic discovery, and identify high-risk individuals for tailored prevention.
Should not yet change stroke prevention practice; leaves open clinical translation of GWAS-identified pathways.
Stroke is the second leading cause of death worldwide and a complex, heterogeneous condition. In this review, we provide an overview of the current knowledge on monogenic and multifactorial forms of stroke, highlighting recent insight into the continuum between these. We describe how, in recent years, large-scale genome-wide association studies have enabled major progress in deciphering the genetic basis for stroke and its subtypes, although more research is needed to interpret these findings. We cover the potential of stroke genetics to reveal novel pathophysiological processes underlying stroke, to accelerate the discovery of new therapeutic approaches, and to identify individuals in the population who are at high risk of stroke and could be targeted for tailored preventative interventions.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a review in Stroke. Stroke genetics was evaluated. Large-scale genome-wide association studies have enabled major progress in deciphering the genetic basis for stroke, revealing novel pathophysiological processes and potential therapeutic approaches.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: